Mandate

Vinge advises AcadeMedia in relation to its listing on Nasdaq Stockholm

June 15, 2016

Vinge advises AcadeMedia AB (publ) and selling shareholders in relation to AcadeMedia’s listing on Nasdaq Stockholm. Trading in the AcadeMedia share on Nasdaq Stockholm commences today, June 15 2016. The price in the offering was set at SEK 40 per share, which corresponds to a value of the total number of shares in the company upon completion of the offering of SEK 3,764 million. Assuming the over-allotment option is exercised in full, the value of the offering will amount to approximately SEK 1,093 million.

AcadeMedia is the leading and single largest independent education provider in northern Europe. In 2014/15, approximately 62,000 children and students attended AcadeMedia’s preschools, compulsory schools and upper secondary schools. An additional 80,000 individuals participated in AcadeMedia’s adult education courses. In 2014/15, AcadeMedia had approximately 400 preschools, compulsory schools and upper secondary schools in Sweden and Norway and approximately 150 adult education units in Sweden. AcadeMedia also has seven preschools in the Munich region of Germany. AcadeMedia has operations throughout the education chain, from preschool, compulsory school and upper secondary school to adult education.

Vinge’s team primarily consists of Erik Sjöman, Dain Hård Nevonen, Christian Lindhé, Ludvig Frithiof, Sofie Bjärtun, Nils Fredrik Dehlin and Astrid Karlsson. Maria Schultzberg and Emelie Parland advise on tax matters.

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025